APTN · Adaptin Bio, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Management has evaluated the Company's operating plan against its existing cash and determined that substantial doubt exists about the Company's ability to support its operations and fund its obligations for the next twelve months from the date of issuance of these condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-09-08 | Zook Anthony P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025. |
Stock Option (right to buy)
|
109,847 |
| 2025-09-08 | Hewitt L Arthur |
Chief Development Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025. |
Stock Option (right to buy)
|
109,847 |
| 2025-09-08 | Riehle J Nick |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025. |
Stock Option (right to buy)
|
109,847 |
| 2025-09-08 | Pedder Simon |
Director, Executive Chairman, 10% Owner |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025. |
Stock Option (right to buy)
|
192,231 |
| 2025-09-08 | Roberts Michael J |
Director, President and CEO, 10% Owner |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025. |
Stock Option (right to buy)
|
439,386 |
| 2025-09-08 | Gallagher Patrick Joseph |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025. |
Stock Option (right to buy)
|
109,847 |
| 2025-09-08 | Maness Timothy |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
50% of the stock option vested on September 8, 2025. The remaining 50% of the stock option vests in equal monthly installments on the last day of each calendar month over 48 months, beginning on September 8, 2025. |
Stock Option (right to buy)
|
192,231 |
| 2025-02-11 | Lucius Partners LLC |
10% Owner |
Other↓
Filing footnotes — Common Stock (Direct)
As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of February 11, 2025, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 1,750,000 shares of Issuer's common stock prior to the consummation of the Merger on February 11, 2025. Matthew Eitner has the power to vote and to dispose of the shares held by Lucius Partners LLC and may be deemed the beneficial owner of the shares. |
Common Stock
|
1,750,000 |